We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Available until 7/1/2021

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

featured
Published in Dermatology

Journal Scan / Research · May 20, 2021

Risks of Basal Cell and Squamous Cell Carcinoma After Treatment of Psoriasis With Biologic vs Non-Biologic Systemic Therapies

Journal of the European Academy of Dermatology and Venereology: JEADV

 

TAKE-HOME MESSAGE

abstract

This abstract is available on the publisher's site.

Access this abstract now  

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the European Academy of Dermatology and Venereology: JEADV
Risks of Basal Cell and Squamous Cell Carcinoma in Psoriasis Patients After Treatment With Biologic vs Non-Biologic Systemic Therapies
J Eur Acad Dermatol Venereol 2021 Apr 18;[EPub Ahead of Print], KJ Mason, AD Burden, JNWN Barker, M Lunt, H Ali, CE Kleyn, K McElhone, MM Soliman, AC Green, CEM Griffiths, NJ Reynolds, AD Ormerod, BADBIR Study Group

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading